Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Antidepressant Drugs: MAOIs and Other Agents01:23

Antidepressant Drugs: MAOIs and Other Agents

Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
Depressive Disorders: MDD and Dysthymia01:27

Depressive Disorders: MDD and Dysthymia

Depressive disorders are a group of mental health conditions characterized by pervasive feelings of sadness, diminished pleasure in life, and a significant impact on daily functioning. These conditions are most prevalent in individuals during their 30s and affect women at twice the rate of men. Contrary to popular belief, younger individuals are generally more susceptible to these disorders than older adults. Two key types of depressive disorders include Major Depressive Disorder (MDD) and...
Antidepressant Drugs: Tricyclics, SSRIs, and SNRIs01:28

Antidepressant Drugs: Tricyclics, SSRIs, and SNRIs

Tricyclic Antidepressants (TCAs), including Desipramine (Norpramin), Imipramine (Tofranil), Clomipramine (Anafranil), and Amitriptyline (Elavil), inhibit serotonin and norepinephrine reuptake and also block other receptors. They are used for depression, pain conditions, and insomnia. Common adverse effects include anticholinergic effects, sedation, orthostatic hypotension, and weight gain. They have a narrow therapeutic window and so require plasma-level monitoring. Abrupt discontinuation can...
Depression: Overview01:18

Depression: Overview

Depression is a prevalent mental illness marked by persistent sadness and lack of interest in previously enjoyable activities. It can take several forms, including major depression, persistent depressive disorder, and bipolar I and II disorders. Symptoms range from emotional changes like chronic worry to physical changes like sleep disturbances and suicidal thoughts. From a neurobiological perspective, depression is believed to be triggered by abnormalities in the brain's prefrontal cortex,...
Depressive Disorders: Etiology01:27

Depressive Disorders: Etiology

Depressive disorders result from a complex interplay of biological, psychological, and sociocultural factors, each contributing uniquely to the development and persistence of the condition. Understanding these factors provides critical insight into the multifaceted nature of depression.
Biological Factors in Depression
Biological predispositions significantly influence the risk of developing depressive disorders. Genetic studies highlight the role of variations in the serotonin transporter...
Long-term Depression01:05

Long-term Depression

Long-term depression, or LTD, is one of the ways by which synaptic plasticity—changes in the strength of chemical synapses—can occur in the brain. LTD is the process of synaptic weakening that occurs over time between pre and postsynaptic neuronal connections. The synaptic weakening of LTD works in opposition to synaptic strengthening by long-term potentiation (LTP) and together are the main mechanisms that underlie learning and memory.

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Cardiac rhythm development: A wearable device index of risk for physical and mental illness in adolescence.

medRxiv : the preprint server for health sciences·2026
Same author

Harmonized psychiatric diagnosis data from the Adolescent Brain Cognitive Development Study.

Research square·2026
Same author

Decomposing neuroanatomical heterogeneity in depression: insights from an ENIGMA major depressive disorder working group study in 5146 individuals.

Translational psychiatry·2026
Same author

Efficient Deep Learning Models for Predicting Individualized Task Activation From Resting-State Functional Connectivity.

Human brain mapping·2026
Same author

Inflammation, fronto-amygdala connectivity, and negative affective reactivity to daily stress in adolescents.

Brain, behavior, & immunity - health·2026
Same author

Trajectories of internalizing problems during and after the COVID-19 pandemic: The effects of sex and early life stress.

Journal of affective disorders·2026
Same journal

The role of sleep in strengthening face learning and memory consolidation: A systematic review.

Cognitive, affective & behavioral neuroscience·2026
Same journal

How the brain represents a romantic partner: Dissociable roles of the nucleus accumbens and anterior insula.

Cognitive, affective & behavioral neuroscience·2026
Same journal

Predictive processing in time perception: Assessing prediction error minimization in the sub-second range.

Cognitive, affective & behavioral neuroscience·2026
Same journal

When attention falters: Brain, breathing, and behavioral signals of lapses in interoceptive attention.

Cognitive, affective & behavioral neuroscience·2026
Same journal

Fronto-Parietal EEG asymmetry interactions predict negative attention bias: A secondary data analysis.

Cognitive, affective & behavioral neuroscience·2026
Same journal

Correction: The neural basis of cost-benefit trade-offs in effort investment: a quantitative activation likelihood estimation meta-analysis.

Cognitive, affective & behavioral neuroscience·2026
See all related articles

Related Experiment Video

Updated: Jun 15, 2026

Individualized rTMS Treatment for Depression using an fMRI-Based Targeting Method
07:12

Individualized rTMS Treatment for Depression using an fMRI-Based Targeting Method

Published on: August 2, 2021

Interference resolution in major depression.

Jutta Joormann1, Derek Evan Nee, Marc G Berman

  • 1Department of Psychology, University of Miami, Coral Gables, Florida, USA.

Cognitive, Affective & Behavioral Neuroscience
|March 18, 2010
PubMed
Summary
This summary is machine-generated.

Major depressive disorder (MDD) is linked to difficulties in clearing negative information from short-term memory. Depressed individuals struggle more with suppressing unwanted negative memories compared to controls.

More Related Videos

Conventional Repetitive Transcranial Magnetic Stimulation for Depression: A Step-by-Step Protocol
10:54

Conventional Repetitive Transcranial Magnetic Stimulation for Depression: A Step-by-Step Protocol

Published on: November 21, 2025

Association Between Sleep Quality and Cognitive Symptoms in Patients with Major Depressive Disorder
04:33

Association Between Sleep Quality and Cognitive Symptoms in Patients with Major Depressive Disorder

Published on: April 26, 2024

Related Experiment Videos

Last Updated: Jun 15, 2026

Individualized rTMS Treatment for Depression using an fMRI-Based Targeting Method
07:12

Individualized rTMS Treatment for Depression using an fMRI-Based Targeting Method

Published on: August 2, 2021

Conventional Repetitive Transcranial Magnetic Stimulation for Depression: A Step-by-Step Protocol
10:54

Conventional Repetitive Transcranial Magnetic Stimulation for Depression: A Step-by-Step Protocol

Published on: November 21, 2025

Association Between Sleep Quality and Cognitive Symptoms in Patients with Major Depressive Disorder
04:33

Association Between Sleep Quality and Cognitive Symptoms in Patients with Major Depressive Disorder

Published on: April 26, 2024

Area of Science:

  • Cognitive Psychology
  • Neuroscience
  • Psychiatry

Background:

  • Major depressive disorder (MDD) is a prevalent mental health condition.
  • Cognitive deficits, particularly in memory and attention, are common in MDD.
  • Understanding interference resolution is crucial for explaining cognitive impairments in depression.

Purpose of the Study:

  • To investigate individual differences in interference resolution in individuals with MDD.
  • To examine the impact of negative emotional stimuli on memory suppression in depression.
  • To differentiate between ignoring irrelevant information and actively suppressing it in short-term memory.

Main Methods:

  • Utilized the
  • ignore/suppress
  • task, a two-step short-term memory paradigm.
  • Assessed response latencies in recognition tasks to measure interference resolution.
  • Compared performance between individuals with MDD and control participants using negative words and neutral letters as stimuli.

Main Results:

  • Depressed participants showed significantly increased interference in the "suppress" step when negative words were used.
  • No group differences in interference were observed during the "ignore" step or when using neutral letters.
  • These findings suggest a specific deficit in actively removing negative information from short-term memory in MDD.

Conclusions:

  • Depression is associated with impaired ability to suppress and remove irrelevant negative material from short-term memory.
  • The observed deficit is specific to negative emotional content, not general interference.
  • These results highlight a potential cognitive mechanism underlying depressive symptoms.